TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
32.21
+0.32 (1.00%)
At close: Sep 5, 2025, 4:00 PM
31.82
-0.39 (-1.21%)
Pre-market: Sep 8, 2025, 8:16 AM EDT
TG Therapeutics Market Cap
TG Therapeutics has a market cap or net worth of $4.70 billion as of September 8, 2025. Its market cap has increased by 22.83% in one year.
Market Cap
4.70B
Enterprise Value
4.70B
1-Year Change
22.83%
Ranking
Category
Stock Price
$32.21
Market Cap Chart
Since May 3, 2010, TG Therapeutics's market cap has increased from $9.10M to $4.70B, an increase of 51,540.60%. That is a compound annual growth rate of 50.21%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 5, 2025 | 5.11B | 9.07% |
Dec 31, 2024 | 4.69B | 81.18% |
Dec 29, 2023 | 2.59B | 50.41% |
Dec 30, 2022 | 1.72B | -36.69% |
Dec 31, 2021 | 2.72B | -60.29% |
Dec 31, 2020 | 6.84B | 518.96% |
Dec 31, 2019 | 1.11B | 225.13% |
Dec 31, 2018 | 339.90M | -41.33% |
Dec 29, 2017 | 579.30M | 127.62% |
Dec 30, 2016 | 254.50M | -59.38% |
Dec 31, 2015 | 626.60M | -10.02% |
Dec 31, 2014 | 696.40M | 433.23% |
Dec 31, 2013 | 130.60M | 43.20% |
Dec 31, 2012 | 91.20M | 91,100.00% |
Dec 30, 2011 | 100.00K | -97.92% |
Dec 31, 2010 | 4.80M | -47.25% |
May 3, 2010 | 9.10M | - |
View and export this data all the way back to 2010. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 652.84B |
Johnson & Johnson | 429.72B |
AbbVie | 375.50B |
UnitedHealth Group | 285.64B |
AstraZeneca | 253.68B |
Novartis AG | 252.55B |
Novo Nordisk | 244.67B |
Abbott Laboratories | 231.38B |